Zoono Group Limited · ASX:ZNO
Zoono — Shareholder Meeting (November 2021)
64 slides from Zoono's shareholder meeting presentation, Nov 25, 2021
Slide 1: Zoono Group Limited AGM Presentation
This presentation has been approved for lodgement with ASX by the Board of Zoono Group Limited.
Slide 2: Board Members
BOARD MEMBERS Don Clarke Elissa Hansen Paul Hyslop Non-Executive Director Director / Company Secretary CEO Zoono Group Limited AGM Presentation November 2021 ZOO NO
Slide 3: Voting results: For, Against, Abstain, Undirected
FOR AGAINST ABSTAIN UNDIRECTED 16,892,689 444,157 48,228 7,331,812 ZOONO GROUP LIMITED AGM PRESENTATION
Slide 4: Voting results: For, Against, Abstain, Undirected
FOR AGAINST ABSTAIN UNDIRECTED 76,442,859 400,407 58,083 7,373,537 ZOONO GROUP LIMITED AGM PRESENTATION
Slide 5: Zoono Group Limited - Paul Hyslop, CEO
ZOONO GROUP LIMITED AGM PRESENTATION (- PAUL HYSLOP CEO ZOONO’
Slide 6: Company Officers
COMPANY OFFICERS Paul Hyslop Lew MacKinnon Paul Ravlich Chief Executive Officer Chief Operating Officer Chief Financial Officer Zoono Group Limited AGM Presentation November 2021 ZOO NO g
Slide 7: Key Management Appointment
KEY MANAGEMENT APPOINTMENT * Barry Woolcott was appointed to the newly established role of Global GM (initial 5-month contract) in October 2021, to support the CEO and executive team, with an emphasis and focus on driving sales efforts. * Barry’s prior roles include 7 years at Deloitte and 13 years
Slide 8: Financial Report
ZOONO GROUP LIMITED FINANCIAL REPORT @ PAUL RAVLICH | GROUP CHIEF FINANCIAL OFFICER ZOONO’ a
Slide 9: Group Financial Highlights June 2021 (NZD)
GROUP FINANCIAL HIGHLIGHTS 30 June 2021 (NZD) ee | ce ——<cs NB: PLEASE REFER TO 30 JUNE 2021 ANNUAL REPORT FOR FURTHER DETAILS a Zoono Group Limited AGM Presentation November 2021 ZOONO lo
Slide 10: Balance Sheet Summary June 2021 (NZD)
BALANCE SHEET SUMMARY 30 June 2021 (NZD) afr $10.6M veel elites (includes Deferred Income of $0.3M) A $21.1M aiiall Ss p:thhy (66% of Total Assets) Zoono Group Limited AGM Presentation November 2021 ZOO N (eo)
Slide 11: Revenue & Other Income & Profit Reported
REVENUE & OTHER INCOME & PROFIT REPORTED $27.1 million Revenue & Other Income 12 months to 30 June 2021 ($38.3 million 30 June 2020) .nzp) $16.1 million Gross Profit 12 months to 30 June 2021 ($28.3 million 30 June 2020) .nz0) $4.6 million profit after tax 12 months to 30 June 2021 ($16.7 million pr
Slide 12: Summary Performance
SUMMARY PERFORMANCE J all cx Strong overall financial Strong cash generation and performance, despite revenues Still high Gross Margins despite strong profitability & margins down down from FY20 Low overheads Low capital investment model Zoono Group Limited AGM Presentation November 2021 ZOO N oO
Slide 13: First Quarter Financial Highlights
FIRST QUARTER FINANCIAL HIGHLIGHTS S4.9M $2.1M S7.5M VW operating cosh in cash receipts operating cash flow invoiced sales (NZD) flow positive p (4) FY 22 (zp) Zoono Group Limited AGM Presentation November 2021 ZOO N oO
Slide 14: The Auckland Office
Slide 15: Market Overview
MARKET OVERVIEW jvowmestorse [apm | STRNIA | LLOYD JOHNS AMERICAS DENNIS MONTGOMERY MIDDLE EAST & AFRICA MICHAEL WU CHINA PIP HOBSON GLOBAL KEVIN STOREY ANIMAL HEALTH a Zoono Group Limited AGM Presentation November 2021 ZOONO
Slide 16: Market Overview - UK and Europe
MARKET OVERVIEW Jamal McCleary Regional Manager United Kingdom and Europe Zoono Group Limited AGM Presentation November 2021
Slide 17: The UK Office
Wiis AHR The UK Office eae = a Tomy,
Slide 18: UK & Europe
UK & EUROPE Jamal McCleary Ashley Malpass Jade Pallett Regional Manager Chief Financial Officer Chief Technical Officer United Kingdom and Europe United Kingdom and Europe United Kingdom and Europe Zoono Group Limited AGM Presentation November 2021 ZOO NO
Slide 19: United Kingdom: Regulatory Approvals
UNITED KINGDOM Regulatory Approvals granted in most EU countries: Austria, Belgium, Bosnia, Croatia, Czech Republic, Denmark, Estonia, France, Germany, Hungary, Ireland, N. Macedonia, Malta, Montenegro, Portugal, Serbia and Sweden. Other EU countries — (WIP) : Albania, Bulgaria, Cyprus, Greece, Koso
Slide 20: United Kingdom: Key Initiative
UNITED KINGDOM Key Initiative * Initiating a new Antimicrobial Standard - PAR (Product Authorisation Request) via Engineering in Medicine and Biology Society Standards Committee (EMBC SC). « Multiple stages / 3 Year process. * If the new Antimicrobial Standard is approved by the IEEE, it can then be
Slide 21: United Kingdom: Health / Hospitals Achievements
UNITED KINGDOM Regional Achievements — Health / Hospitals: * Hungary: Testing has confirmed a 77% reduction in Clostridium difficile (C.diff) infections, 2 months after the use of Zoono Z-71 was initiated. * South-East Europe: Hospitals now using Zoono Z-71. * UK: Successful trials have led to a rol
Slide 22: United Kingdom: Facilities Management Achievements
UNITED KINGDOM Regional Achievements - Facilities Management (FM) * Working with current FM partners to increase brand awareness / market share. * Successful rollout via one of the largest UK Hotel chains, has been extended across the Group. In turn, this has led to new opportunities with another Eu
Slide 23: United Kingdom: Food Packaging
UNITED KINGDOM Other Initiatives — Food Packaging * As aresult of the successful South African packaging trials, Zoono is working with a major UK supermarket chain to deliver treated packaging solutions that will increase shelf life. * Interest is widespread from the food production sector. We are c
Slide 24: United Kingdom: 2021 Cleaning Show Excel
UNITED KINGDOM Other Initiatives - 2021 Cleaning Show Excel * Successful first attendance by Zoono at the UK Cleaning Show. * Very busy stand. Most interactions were with cleaning Companies wanting to utilise Zoono as part of their service offering. * Positive feedback has also highlighted marketing
Slide 25: UK / Europe: France
UK / EUROPE Regional Achievements — France * Strategic gains have been achieved via major Facilities Management (FM) companies and Hotel / Hospitality Groups. This will enable Zoono to expand internationally via Icon brand Companies - including the ability for Zoono to use advocate sites. * Transpor
Slide 26: UK / Europe: Poland and South-East Europe
UK / EUROPE Regional Achievements — Poland * Successful trials completed within Transportation (Rail). * Additional trials are underway in Agriculture. * Sales into Poland are growing steadily. Regional Achievements - South-East Europe * Significant gains achieved in the medical, hospitality and Gov
Slide 27: UK / Europe: Further Regional Achievements
UK / EUROPE Further Regional Achievements: Bulgaria registrations complete. Distributor appointed. Trials nearing completion within Transportation (Rail). Malta - Pharmacy chain now supporting Zoono brands, plus Dental clinics, Council, Residential nursing homes. Sales of Zoono brands have just comm
Slide 28: UK / Europe: Strategic Summary
UK / EUROPE Strategic Summary Support, Educate, Identify, Recruit Recent strategy has been to support distributors by providing Zoono technical and sales personnel for customer meetings. SharePoint has been upgraded to provide both technical info and marketing collateral. Education is key for our te
Slide 29: Market Overview - Australia & New Zealand
MARKET OVERVIEW AUSTRALIA & NEW ZEALAND PAUL MORRISON DOMINIC STOREY REGIONAL MANAGER BUSINESS DEVELOPMENT MANAGER AUSTRALIA & NEW ZEALAND AUSTRALIA ZOONO’
Slide 30: New Zealand
NEW ZEALAND * Rationalisation of storage / warehousing has reducing operational costs significantly. * Listed product supplier to New Zealand Defence Force with application to all NZ Navy Platforms. * B2B sector now looking beyond Covid with a ‘Prevention Focus’ across all Education and Transport se
Slide 31: New Zealand
NEW ZEALAND * Bedding in the Partner Program with Authorised Service Providers (ASP) and Authorised Resellers (AR). Both programs to be tailored for a global roll out. * Successful rollout of Zoono’s Automotive offering focusing on Fleet and Companion Transport using recurring revenue / subscription
Slide 32: Australia
AUSTRALIA * Zoono individual wipes continue to be part of the QANTAS “Fly Well” program. * Cabin Services aligned with Zoono within the Aviation sector. * Continued reach into the Education Sector via both Early Child Education and the broader Tertiary environment. * Formalisation of product accepta
Slide 33: Australia
AUSTRALIA * Working to increase use of Zoono products across the wider ADF (Australian Defense Force) Bases including administration and corporate platforms. * Good growth within the public transport sectors with Zoono fast becoming a product of choice in both Airports and Rail environments. * Ratio
Slide 34: https://clickresearch.com.au
• • https://clickresearch.com.au
Slide 35: Australia: The Future
AUSTRALIA The Future: * Developing vertical markets where Zoono is already present - especially public transport, airports, strata management, office supply, food manufacturing and production. * Alignment with key distribution partners in Australia is essential. Zoono Australia will work closely wit
Slide 36: Market Overview - Americas
MARKET OVERVIEW AMERICAS LLOYD JOHNS REGIONAL MANAGER ZOONO’
Slide 37: Zoono Holdings USA
ZOONO HOLDINGS USA Operations * Zoono Holdings USA LLC commenced operations in the USA on 1st November 2020. * The new Company replaces the former Distributor - also based in Shrewsbury, NJ. * Regulatory - New EPA registration lodged that is expected to enable further claims including anti viral - e
Slide 38: Market Overview - Middle East & Africa
MARKET OVERVIEW MIDDLE EAST & AFRICA DENNIS MONTGOMERY GARRY WILSON REGIONAL MANAGER BUSINESS DEVELOPMENT — SOUTH AFRICA ZOONO’
Slide 39: Middle East: EXPO2020
MIDDLE EAST EXPO2020 has finally arrived! It may be one year later than planned, but in the first month alone, 2,350,868 visitors attended EXPO2020! We are delighted that Zoono Z-71 Surface Sanitiser and Zoono GermFree24 Hand Sanitiser have been the product of choice for both the New Zealand and the
Slide 40: Middle East
MIDDLE EAST * Zoono Surface Sanitiser has been validated for up to 30-days protection and Zoono Hand Sanitiser for up to 24 hours by ESMA - Emirates Authority for Standardization & Metrology. * Independent GLP lab tests in the UAE have proven our efficacy and longevity and this will further enhance
Slide 41: Middle East
MIDDLE EAST * Zoono is working with a large hotel group in the Middle East where our initial test results have exceeded their expectations. * Zoono has been applied to all surface areas within the hotels, such as: hotel rooms, staff areas, food preparation areas, fitness centres, elevators, cafes, b
Slide 42: South Africa
SOUTH AFRICA * Zoono South Africa has been established in Cape Town - October 2021. This office will be the springboard for distributor activity across the African continent. * On-line shopping portal being introduced January 2022. * Extensive trials in packaging has led to initial orders of Z-71 Mi
Slide 43: South Africa: Packaging and Cartons
SOUTH AFRICA * Packaging and Cartons * Zoono worked closely with one of South Africa’s leading producers of dried fruit to deliver a solution to a long-standing issue of mould appearing on cartons being shipped in containers. * Zoono was applied during the manufacturing process of the cardboard cart
Slide 44: Market Overview - China
MARKET OVERVIEW CHINA MICHAEL WU BUSINESS MANAGER ZOONO’
Slide 45: China Market Achievements
CHINA MARKET ACHIEVEMENTS ZOONO ALIBABA GLOBAL FIRST GRADE APPROVAL & WAREHOUSE ESTABLISHED IN SOLID AND GROWING FLAGSHIP STORE PRODUCT REGISTRATION OF SHANGHAI FOR CROSS BORDER CUSTOMER BASE IN IMPORTED DISINFECTANT TRADING AND GENERAL CHINA AND HONG KONG PRODUCTS BY CHINA HEALTH IMPORTING BUSINESS
Slide 46: Market Update: Consumer Market
MARKET UPDATE Consumer Market: * Zoono opened a cross-border flagship store in = | TMall global, in September 2020. i a * From a zero base, sales have steadily increased . A month on month. ZOONO + . . ~~ MICROBE * Currently working with China's largest e- han [ _ SHIELD commerce operators to maximi
Slide 47: Market Update: Commercial Market
MARKET UPDATE Commercial Market: * The commercial market is Zoono’s prime focus. * Zoono China was set up in Shanghai in March 2021. The strategy has been to identify and work with sector leading Chinese companies who have strong channel resources. * Significant gains have been achieved in some key
Slide 48: Other Achievements
OTHER ACHIEVEMENTS * Zoono China has achieved significant breakthroughs in airports, airlines, high-speed rail, railway stations, urban subways and other public transport fields. * Zoono is now being used in VIP lounges at major airports in China through the support of China Southern Airlines. * Zoo
Slide 49: Zoono Animal Health
* Zoono Animal Health is an independent Distributor specialising in the Animal Health sector
Slide 50: Overview
OVERVIEW * The Animal Health sector is a gradual entry process for ZOONO. * It takes 1- 2 years to implement the ZOONO product as a replacement for existing veterinary products. * The industry norm is to start with a trial (poultry or swine). This can take 6-12 months to complete — before any roll o
Slide 51: Market Update: New Zealand - Australia
MARKET UPDATE New Zealand - Australia * Zoono has been proven in three large Poultry companies who are at various stages of implementing the product within their businesses. * The highly regarded lowa State University has completed studies over the past 14 months. * The studies confirmed that unlike
Slide 52: Market Update: APIAM Partnership
MARKET UPDATE * APIAM (ASX:AHX) have partnered with Zoono Animal Health for the international roll out of Zoono products. * Zoono Animal Health have a direct supply Agreement with APIAM for agreed markets. + APIAM have partnered with a Veterinary distributor for the launch and distribution of Zoono
Slide 53: Market Update: UK & Europe
MARKET UPDATE UK & Europe * Working with our UK Animal Health partners, we are currently in advanced discussions and/or field trials with the 3 largest y companies in the UK. (Collectively, they produce 90% of the Uys — < naa ER processed chicken). * Trials were held over three consecutive breeding
Slide 54: Market Update: UK & Europe
MARKET UPDATE UK & Europe * R&D for improving the performance of Z-71 into the various sectors of the poultry industry is an ongoing process that is carried out in NZ - a within a poultry company that supports our technology. een L LT TE * The R&D provides constant refinements to the application pro
Slide 55: Market Overview - Marketing
MARKET OVERVIEW PIP HOBSON MARKETING MANAGER ZOONO’
Slide 56: Marketing Activity - Reflection
MARKETING ACTIVITY-REFLECTION * Tool kit of professional brand assets and sales i materials available. * Navigation of strict regulatory requirements Ss around the world. * New global business website plus regional online stores. * 8new Zoono branded company websites FN around the world. ‘Traditiona
Slide 57: Marketing Activity - Reflection
MARKETING ACTIVITY-REFLECTION * Make A Wish Partnership and commercial opportunities * Further social initiatives * New label design for non-skin products. * Content creation; real customer testimonials and case studies — Headmaster Tim O’Connor from one of New Zealand's leading secondary schools ta
Slide 58: Market Segmentation - Strategic Insight
MARKET SEGMENTATION- STRATEGIC INSIGHT We Gh Bi FAMILIES/ SMALL BUSINESS MEDIUM BUSINESS LARGE BUSINESS B2C CUSTOMERS/B2B CUSTOMERS/B2B CUSTOMERS/B2B l i} l i} AD OBJECTIVE: Online Sales AD OBJECTIVE: Lead Generation Customers Profiles & Segments 5 Customised Messages Zoono Group Limited AGM Present
Slide 59: New Digital Partners
NEW DIGITAL PARTNERS * Sydney-based digital marketing specialist will focus on growing brand awareness, online sales and lead generation. * Defiant specialise in paid ads and SEO. * Outsourcing this task will allow our team to focus other essential roles. ZOONO Stop germs in heir tracks Zoono Group
Slide 60: Marketing Activity - 2022 Focus Points
MARKETING ACTIVITY- 2022 FOCUS POINTS * Global expansion via Amazon; alignment and expansion into EU markets. * B2B marketing priority over B2C, online & lead generation important. * Content marketing * Lead generation campaigns. * Support global sales team; marketing tools and strategic marketing a
Slide 61: FY22 Priorities
FY22 PRIORITIES PAUL HYSLOP CEO ZOONO’
Slide 62: FY22 Priorities
FY22 PRIORITIES 3 Continue to transition and stabilise from the COVID induced fai environment into delivering ongoing, long-term, sustainable and repeatable sales growth by: - af# iS > Y Continuing to invest significantly in our direct global sales struc’ i } key geographic markets. ¥ Supporting exi
Slide 63: Important Notice & Disclaimer
Important Notice & Disclaimer Commercial in Confidence Zoono has not audited or investigated the accuracy or completeness of the information, statements and opinions contained in this presentation. Whilst provided in good faith, to the maximum extent permitted by applicable laws, Zoono makes no repr
Slide 64: Questions?
ZOONO The next generation of antibacterial technology Questions? Zoono Group Limited AGM Presentation November 2021 ZOO NO